|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Contrast Media |
1 From the Department of Radiology (M.R.J., J.B., J.R.), Nephrology (P.D.), and Pulmonology (I.T.L.), Hospital Calmette, University Center of Lille, Boulevard Jules Leclerc, 59037 Lille, France; Schering SA, Lys-Lez-Lannoy, France (O.E.); and Department of Medical Statistics, University of Lille, France (A.D.). Received April 23, 2004; revision requested July 1; revision received July 22; accepted August 18. Address correspondence to M.R.J. (e-mail: mremy-jardin@chru-lille.fr).
PURPOSE: To prospectively evaluate the safety and effectiveness of gadolinium-enhanced multidetector row spiral computed tomographic (CT) angiography of the pulmonary circulation by using two gadolinium doses in patients with contraindications to iodinated contrast agents.
MATERIALS AND METHODS: Study was approved by the Ethics Committee, and written informed consent was obtained. Thirty-seven patients (20 men, 17 women) with contraindications to iodinated contrast agents (allergic reactions, n = 27; impaired renal function, n = 10) underwent CT angiography of the pulmonary circulation in search of acute pulmonary embolism (n = 28) or for management of tumoral disease (n = 9). CT angiography was performed (a) with fourdetector row (n = 19) or 16detector row (n = 18) scanners; (b) at randomly assigned gadolinium doses of either 0.3 mmol per kilogram of body weight (n = 19) or 0.4 mmol/kg (n = 18); and (c) with a systematic evaluation of clinical and biologic tolerance of gadolinium. Comparison of percentages between group 1 and group 2 scans was performed with the
2 or the Fisher exact test. An unpaired Wilcoxon rank sum test was used for numeric variables. P < .05 was considered to indicate a significant difference.
RESULTS: The mean (± standard deviation) volume of gadopentetate dimeglumine administered in the overall study group was 48 mL ± 9.6 (range, 2965 mL). The level of maximal enhancement in the pulmonary arteries was significantly higher in group 2 than in group 1 (215.8 HU ± 95 vs 141.3 HU ± 44) (P = .02) and was maintained throughout the entire region of interest in a greater number of examinations in group 2 than in group 1 (n = 16 [89%] vs n = 2 [10.5%]) (P < .0001). The number of diagnostic CT angiograms was significantly higher in group 2 than in group 1 (n = 17 [94%] vs n = 13 [68%]) (P = .007). Significant but transient reduction of creatinine clearance was observed in one patient with preexisting moderate chronic renal failure (0.3 mmol/kg gadolinium dose).
CONCLUSION: High-quality gadolinium-enhanced CT angiograms require the use of 16detector row CT technology; the doses administered did not alter the renal function except transiently in one patient.
© RSNA, 2005
This article has been cited by other articles:
![]() |
J. C. Weinreb Which Study When? Is Gadolinium-enhanced MR Imaging Safer than Iodine-enhanced CT? Radiology, October 1, 2008; 249(1): 3 - 8. [Full Text] [PDF] |
||||
![]() |
U. Nyman, B. Elmstahl, and P. Leander Suggesting Gadolinium-based Contrast Media for CT in Azotemic Patients Is Not Based on Historical, Clinical, and Experimental Data Radiology, August 1, 2007; 244(2): 622 - 623. [Full Text] [PDF] |
||||
![]() |
M. Kalinowski, K. Goldmann, M. Gotthardt, M. Rossler, A. Pfestroff, K. J. Klose, and H.-J. Wagner Effectiveness and Renal Tolerance of Multidetector Helical CT with Gadobutrol: Results of a Comparative Porcine Study Radiology, August 1, 2007; 244(2): 457 - 463. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Rakita, A. Newatia, J. J. Hines, D. N. Siegel, and B. Friedman Spectrum of CT Findings in Rupture and Impending Rupture of Abdominal Aortic Aneurysms RadioGraphics, March 1, 2007; 27(2): 497 - 507. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Heinrich, M. K. Kuhlmann, S. Kohlbacher, M. Scheer, A. Grgic, M. B. Heckmann, and M. Uder Cytotoxicity of Iodinated and Gadolinium-based Contrast Agents in Renal Tubular Cells at Angiographic Concentrations: In Vitro Study Radiology, December 19, 2006; (2006) 2422060245. [Abstract] [Full Text] |
||||
![]() |
J. Becker, H. Thompson, M. Remy-Jardin, J. Remy, and P. Dequiedt Renal Safety of Gadolinium-based Contrast Agent for Ionizing Radiation Imaging. Radiology, July 1, 2006; 240(1): 301 - 302. [Full Text] [PDF] |
||||
![]() |
M. Remy-Jardin, J. Bahepar, J.-J. Lafitte, P. Dequiedt, O. Ertzbischoff, J. Bruzzi, V. Delannoy-Deken, A. Duhamel, and J. Remy Multi-Detector Row CT Angiography of Pulmonary Circulation with Gadolinium-based Contrast Agents: Prospective Evaluation in 60 Patients Radiology, March 1, 2006; 238(3): 1022 - 1035. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Morcos and M. Remy-Jardin Gadolinium-based Contrast Media for Multi-Detector Row Spiral CT Pulmonary Angiography in Patients with Renal Insufficiency Radiology, March 1, 2006; 238(3): 1077 - 1078. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| RADIOLOGY | RADIOGRAPHICS | RSNA JOURNALS ONLINE |